• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Difficult or Delayed Positioning (1157)
Patient Problems Low Blood Pressure/ Hypotension (1914); Atrial Perforation (2511)
Event Date 11/20/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the perforation requiring a transfusion.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4.The patient became unstable after the steerable guide catheter (sgc) was introduced to the fossa.There were problems due to a kinked femoral vein, but the sgc was able to be advanced.While pushing the sgc through the fossa, the guide wire in the left atrium and the sgc were lost.The patients blood pressure decreased and a perforation was noted; therefore, the sgc was removed and a transfusion was performed.Prolonged hospitalization was needed.No additional information was provided.
 
Manufacturer Narrative
Internal file number - (b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Additionally, a review of the complaint history identified no similar incidents reported from this lot.All available information was investigated, and the reported physical resistance leading to device operates differently than expected appears to be related due to patient pathology/morphology (kinked femoral vein).The reported cardiac perforation appears to be related due to procedural circumstances (pushing of sgc).The reported hypotension can be a cascading effect of perforation, however definitive cause could not be determined in this case.The reported patient effects of hypotension and cardiac perforation (atrial perforation) as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
Subsequent to the initially filed medwatch, additional information received noted the patient was sent to surgery for treatment, and discharged home a few days later.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8151286
MDR Text Key129932766
Report Number2024168-2018-09533
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/24/2019
Device Catalogue NumberSGC0302
Device Lot Number80824U260
Was Device Available for Evaluation? No
Date Manufacturer Received02/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
GUIDE WIRE; GUIDE WIRE
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age88 YR
-
-